We provide individualised Autologous Precursor Stem Cells and FCTI ASI Therapy for the treatment of chronic/untreatable diseases such as Autism, Down Syndrome, Cerebral Palsy, Parkinson's Disease, Diabetes Mellitus, Cancer, and etc.

BRIEF HISTORY ON STEM CELL THERAPY

Stem Cell Therapy (SCT) is no stranger in the field of clinical practice as it has been around for about 80 years. A great number of patients have gained, especially in Germany and Switzerland, from stem cell therapy. FCTI Inc. has revolutionised an improved method after twenty years of extensive research, GMP (good manufacturing practice) and clinical experience to enable physicians to treat patients with precision while not compromising on the safety aspects. FCTI stands at the threshold of ‘regenerative’ medicine where autologous precursor stem cells, manufactured via its FCTI proprietary primary tissue culture, can potentially restore functions to injured, diseased and debilitated tissues and organs. SCT is the leading biomedical science in the rapidly emerging field of regenerative medicine.

WHY SHOULD WE CHOOSE FCTI?

FCTI is the world’s largest provider of Autologous Stem Cell Therapy using the FCTI Proprietary procedure of primary cell tissue culture. Below are our statistics:

10 years+	10 years+	20 years+
Ahead in Biotechnology and Know-How	Commercial Manufacturing	Research and Development